EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,432,624 | +35.0% | 217,668 | +66.5% | 0.01% | +22.2% |
| Q2 2023 | $2,541,799 | -48.7% | 130,751 | -25.1% | 0.01% | -50.0% |
| Q1 2023 | $4,955,104 | +150924.2% | 174,660 | +55.6% | 0.02% | +50.0% |
| Q4 2022 | $3,281 | -99.8% | 112,252 | +44.7% | 0.01% | +50.0% |
| Q3 2022 | $2,049,000 | -44.6% | 77,557 | -6.9% | 0.01% | -42.9% |
| Q2 2022 | $3,699,000 | -14.8% | 83,264 | -5.1% | 0.01% | +16.7% |
| Q1 2022 | $4,342,000 | +63.7% | 87,729 | +68.5% | 0.01% | +50.0% |
| Q4 2021 | $2,652,000 | +10.5% | 52,080 | +21.0% | 0.01% | 0.0% |
| Q3 2021 | $2,401,000 | – | 43,043 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |